After losing over $16 billion of market capitalization edwards lifesciences (ew) faces investor class action - hagens berman

Ew investors with losses encouraged to contact the firm san francisco, ca / accesswire / november 8, 2024 / hagens berman urges edwards lifesciences corporation (nyse:ew) investors who suffered substantial losses to submit your losses now. class period: feb. 6, 2024 - july 24, 2024 lead plaintiff deadline: dec. 13, 2024 visit: www.hbsslaw.com/investor-fraud/ew contact the firm now: ew@hbsslaw.com 844-916-0895 class action lawsuit against edwards lifesciences corporation (ew): the litigation is focused on the propriety of edwards lifesciences' disclosures about its core product, the transcatheter aortic valve replacement ("tavr") platform.
EW Ratings Summary
EW Quant Ranking